New research in MS was presented at AAN 2023, the annual meeting of the American Academy of Neurology. The features below highlight some of the studies presented during the conference. Gold Nanocrystals May Be Effective as...
Patient-reported outcome (PRO) Andrew Lloyd, DPhil measures in MS clinical trials of disease-modifying treatment are not evidence-based or “underpinned by structured systematic approaches,” according to findings published in...
White individuals have the highest prevalence of MS, according to a study published in JAMA Neurology. Mitchell T. Wallin, MD, MPH, and colleagues calculated the US prevalence of MS in Hispanic, non-Hispanic Black, and non-...
Smoking exhibits an adverse relationship with cognition and gray matter fraction (GMF) among patients with MS, according to findings published in Multiple Sclerosis Journal. Devon Conway, MD, and colleagues conducted a...
Compared with White patients with MS, Black and Hispanic patients with MS have different demographic characteristics and disease burdens, according to results published in Multiple Sclerosis and Related Disorders. Lilyana...